NCT02359214View on ClinicalTrials.gov

Effect of Vitamin D3 Supplementation on Cardiometabolic Risk

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Cardiovascular DiseaseDiabetesBone Disease
Interventions
DIETARY_SUPPLEMENT

Vitamin D3

5000IU (125mcg) vitamin D3 tablet daily over 8 weeks (56 days).

OTHER

Placebo

100% Lactose tablet daily over 8 weeks (56 days).

Trial Locations (1)

CH1 4BJ

University of Chester, Chester

All Listed Sponsors
lead

University of Chester

OTHER

NCT02359214 - Effect of Vitamin D3 Supplementation on Cardiometabolic Risk | Biotech Hunter | Biotech Hunter